{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:42:20Z","timestamp":1789796540634,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.mjafi.2026.01.024","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:38:28Z","timestamp":1775684308000},"page":"516-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A systematic review and meta-analysis of non-alcoholic fatty liver disease (NAFLD) versus non-NAFLD among diabetes mellitus patients"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7025-1747","authenticated-orcid":false,"given":"Shalini","family":"Balamurugan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8405-1897","authenticated-orcid":false,"given":"Reenaa","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0497-7971","authenticated-orcid":false,"given":"Tresa Remya Athipozhi","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8869-2416","authenticated-orcid":false,"given":"Mary J.","family":"Jenifer Florence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6673-6171","authenticated-orcid":false,"given":"Rajalakshmi","family":"Mahendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8309-2865","authenticated-orcid":false,"given":"Jeyakumar","family":"Manavalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pai R.","family":"Balakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2581-0820","authenticated-orcid":false,"given":"Sanjay","family":"Pasupathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5460-6575","authenticated-orcid":false,"given":"Muthu","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mjafi.2026.01.024_bib1","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mjafi.2026.01.024_bib2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2337\/dc10-2229","article-title":"Prevalence of and risk factors for hepatic steatosis and non-alcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh type 2 diabetes study","volume":"34","author":"Williamson","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.mjafi.2026.01.024_bib3","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.mjafi.2026.01.024_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/ijem.IJEM_585_17","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus","volume":"22","author":"Dharmalingam","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.mjafi.2026.01.024_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-019-0961-9","article-title":"Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"19","author":"Pu","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.mjafi.2026.01.024_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.mjafi.2026.01.024_bib7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.mjafi.2026.01.024_bib8","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mjafi.2026.01.024_bib9","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/hep.26465","article-title":"Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mjafi.2026.01.024_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.mjafi.2026.01.024_bib11","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s00464-016-5082-8","article-title":"The effects of bariatric surgeries on nonalcoholic fatty liver disease","volume":"31","author":"Aldoheyan","year":"2017","journal-title":"Surg Endosc"},{"key":"10.1016\/j.mjafi.2026.01.024_bib12","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.mjafi.2026.01.024_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and Mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.mjafi.2026.01.024_bib14","series-title":"Review Manager (RevMan)-Computer Program","year":"2020"},{"key":"10.1016\/j.mjafi.2026.01.024_bib15","volume":"vol. 26","author":"Santos","year":"2018"},{"issue":"2","key":"10.1016\/j.mjafi.2026.01.024_bib16","first-page":"78","article-title":"Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 DM","volume":"12","author":"Suryawanshi","year":"2023","journal-title":"Int J Med Res Health Sci"},{"issue":"6","key":"10.1016\/j.mjafi.2026.01.024_bib17","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4254\/wjh.v14.i6.1226","article-title":"Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus","volume":"14","author":"Yamane","year":"2022","journal-title":"World J Hepatol"},{"key":"10.1016\/j.mjafi.2026.01.024_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-01192-4","article-title":"Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study","volume":"20","author":"Ichikawa","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"10.1016\/j.mjafi.2026.01.024_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236977","article-title":"Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus","volume":"15","author":"Chen","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mjafi.2026.01.024_bib20","first-page":"42","article-title":"Study of prevalence of nonalcoholic fatty liver disease [NAFLD] by non invasive diagnostic criteria in type 2 diabetes mellitus patients","volume":"7","author":"Patel","year":"2017","journal-title":"Int J Health Sci Res"},{"issue":"4","key":"10.1016\/j.mjafi.2026.01.024_bib21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2016-3440","article-title":"Association of NAFLD with diabetes and the impact of BMI changes: a 5-year cohort study based on 18,507 elderly","volume":"102","author":"Liu","year":"2017","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.mjafi.2026.01.024_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5455\/2320-6012.ijrms20140523","article-title":"Study of association of non alcoholic fatty liver disease (NAFLD) with micro and macrovascular complications of type 2 diabetes mellitus (T2DM)","volume":"2","author":"Somalwar","year":"2014","journal-title":"Int J Res Med Sci"},{"issue":"20","key":"10.1016\/j.mjafi.2026.01.024_bib23","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.3748\/wjg.v19.i20.3134","article-title":"Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes","volume":"19","author":"Lv","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.mjafi.2026.01.024_bib24","doi-asserted-by":"crossref","first-page":"14698","DOI":"10.3390\/ijms131114698","article-title":"Non-alcoholic fatty liver disease is not related to the incidence of diabetic nephropathy in type 2 diabetes","volume":"13","author":"Zhan","year":"2012","journal-title":"Int J Mole Sci"},{"issue":"7","key":"10.1016\/j.mjafi.2026.01.024_bib25","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ajg.2010.18","article-title":"Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study","volume":"105","author":"Adams","year":"2010","journal-title":"Am Coll Gastroenterol"},{"key":"10.1016\/j.mjafi.2026.01.024_bib26","first-page":"351","article-title":"Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes","volume":"59","author":"Agarwal","year":"2011","journal-title":"J Assoc Phys India"},{"issue":"1","key":"10.1016\/j.mjafi.2026.01.024_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diabres.2008.11.039","article-title":"Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome","volume":"84","author":"Mohan","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.mjafi.2026.01.024_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus","volume":"29","author":"Leite","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.mjafi.2026.01.024_bib29","first-page":"188","article-title":"Association of non-alcoholic fatty liver with type 2 diabetes mellitus","volume":"9","author":"Luxmi","year":"2008","journal-title":"Jlumhs"},{"issue":"5","key":"10.1016\/j.mjafi.2026.01.024_bib30","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc06-2247","article-title":"Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mjafi.2026.01.024_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13098-022-00930-w","article-title":"Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes","volume":"14","author":"Lin","year":"2022","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"10.1016\/j.mjafi.2026.01.024_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13098-022-00814-z","article-title":"NAFLD in normal weight individuals","volume":"14","author":"DiStefano","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.mjafi.2026.01.024_bib33","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2147\/DMSO.S203937","article-title":"Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women","author":"Albracht-Schulte","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"4","key":"10.1016\/j.mjafi.2026.01.024_bib34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.mjafi.2026.01.024_bib35","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.mjafi.2026.01.024_bib36","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1210\/jc.2007-0482","article-title":"Liver fat in the metabolic syndrome","volume":"92","author":"Kotronen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mjafi.2026.01.024_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-020-01326-3","article-title":"Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study","volume":"19","author":"Zou","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.mjafi.2026.01.024_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4158\/CS-2019-0472","article-title":"Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm\u20132020 executive summary","volume":"26","author":"Garber","year":"2020","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.mjafi.2026.01.024_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.mjafi.2026.01.024_bib40","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4254\/wjh.v14.i4.791","article-title":"Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B","volume":"14","author":"Zhou","year":"2022","journal-title":"World J Hepatol"},{"issue":"6","key":"10.1016\/j.mjafi.2026.01.024_bib41","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/hep.23593","article-title":"Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the framingham heart study","volume":"51","author":"Speliotes","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.mjafi.2026.01.024_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013781","article-title":"Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the Non-obese Chinese population: a cross-sectional and longitudinal study","volume":"6","author":"Sun","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.mjafi.2026.01.024_bib43","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3892\/br.2014.309","article-title":"Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes","volume":"2","author":"Tomizawa","year":"2014","journal-title":"Biomed Rep"},{"issue":"4","key":"10.1016\/j.mjafi.2026.01.024_bib44","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cgh.2022.01.046","article-title":"Influence of nonalcoholic fatty liver disease with increased liver enzyme levels on the risk of cirrhosis and hepatocellular carcinoma","volume":"21","author":"Huang","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mjafi.2026.01.024_bib45","article-title":"Elevated ALT\/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States","volume":"15","author":"Xuan","year":"2024","journal-title":"Front Endogrinol"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123726000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123726000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:29:14Z","timestamp":1789748954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123726000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0377123726000687"],"URL":"https:\/\/doi.org\/10.1016\/j.mjafi.2026.01.024","relation":{},"ISSN":["0377-1237"],"issn-type":[{"value":"0377-1237","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of non-alcoholic fatty liver disease (NAFLD) versus non-NAFLD among diabetes mellitus patients","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mjafi.2026.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}